Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
about
Angiotensin II inhibits the Na+-K+ pump via PKC-dependent activation of NADPH oxidaseBiochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular systemNADPH oxidases in heart failure: poachers or gamekeepers?Small G proteins in the cardiovascular system: physiological and pathological aspectsAngiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophyIL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemNovel aspects of the roles of Rac1 GTPase in the cardiovascular systemConcerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IISuperoxide scavenging and Akt inhibition in myocardium ameliorate pressure overload-induced NF-κB activation and cardiac hypertrophy.Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?A differential role for endocytosis in receptor-mediated activation of Nox1.Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis.Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice.Local angiotensin II aggravates cardiac remodeling in hypertension.Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2.Redox signaling in cardiac myocytes.Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemiaExercise training reduces cardiac dysfunction and remodeling in ovariectomized rats submitted to myocardial infarction.NADPH oxidase: recent evidence for its role in erectile dysfunction.NOX2-derived reactive oxygen species are crucial for CD29-induced pro-survival signalling in cardiomyocytesMitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling.Group V secretory phospholipase A2 enhances the progression of angiotensin II-induced abdominal aortic aneurysms but confers protection against angiotensin II-induced cardiac fibrosis in apoE-deficient mice.CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.Regulation of the instantaneous inward rectifier and the delayed outward rectifier potassium channels by Captopril and Angiotensin II via the Phosphoinositide-3 kinase pathway in volume-overload-induced hypertrophied cardiac myocytes.Novel Roles for Peroxynitrite in Angiotensin II and CaMKII SignalingMyocardial AKT: the omnipresent nexus.Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons.Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.Nox2 and Nox4 influence neonatal c-kit(+) cardiac precursor cell status and differentiation.Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction.Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.Cell-specific effects of Nox2 on the acute and chronic response to myocardial infarction.NADPH oxidases and angiotensin II receptor signalingGenetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II.NADPH oxidase in brain injury and neurodegenerative disordersThe basic biology of redoxosomes in cytokine-mediated signal transduction and implications for disease-specific therapies.NADPH oxidase and cardiac failure.NADPH oxidases and cardiac remodelling.Regulation of myocardial growth and death by NADPH oxidase.
P2860
Q24336297-854770EC-179E-446A-91BC-334ABE7AA1CFQ26991619-2C126588-72FB-454B-A678-6ECBCD54A580Q27001094-2E9A4E83-0A2E-49F5-8519-FD67D0CADB23Q27010607-AA443218-0B71-43B8-A42F-5DBC763C49DBQ28566875-19E3B05F-C5A3-4AC2-B601-4C24AC76B04BQ28585033-BD4477F3-2A17-4399-AD1F-F8182E6E7E44Q33746458-0684CA65-9347-48F6-A972-1D6000C94542Q33769656-59F5651E-2078-4E20-AD96-72D0B3B13CD5Q33786440-67FFA1D8-AA59-4416-8582-DE82EB34F29DQ33807091-790FE508-583D-414A-AF2B-E7B62D16F5B4Q33818158-7BAE1869-F1F4-4D0B-81BD-C808D0D9D97CQ33921217-BE38938B-6A60-453F-81F5-AFE615CF41B8Q34091379-1663307F-6379-4D2C-BD90-D7C589BE4DDAQ34357832-8907BEE6-25FE-47E2-A6A0-8A65DA1FD579Q34570989-F73CB1D4-4AFB-4E82-B2BD-A1D39FD1098FQ34629326-9E56CE2E-E005-47BC-A662-F043CA4B17F0Q34685260-60CEB438-9442-4CA1-AA83-673A2AF68435Q34796545-F80735A6-36E7-47DE-8B5B-CC1E095D0B29Q35301338-E2ECE72D-6ADA-47DB-BEC7-3740825E89A6Q35766055-1AF41EE5-F903-42E3-B08F-2BBD845949E3Q35976043-120E92BD-BDB6-4EC4-9470-248F4D4D2632Q36119104-09AEC630-7892-42F6-9EDC-7B1D6F2C5D59Q36204176-DD7CC396-8DE9-4EFD-A40A-64DCD6ABA09AQ36337179-5B56F037-68C7-45FF-88C1-9CE7D9DB66B4Q36516502-833C9400-35DF-4E14-9642-3201A56A10A2Q36799541-A87E91E8-62FD-4296-9DF0-B5BA55C0F09CQ36908289-56415BAB-2428-4E90-87AE-5C65CE9F1F58Q37054954-2F54A4D8-816F-4DFB-86CD-2EE19C2181B5Q37071136-EF98D662-48F0-4FE1-A525-0CE4AAAFBC74Q37142792-664596EE-559D-4895-84A1-8BF2C89356EFQ37161877-7B8D378A-F8D3-42F3-B2E9-7EC46063D267Q37166958-9AB0F5F5-2F53-4FFB-8A4F-FA9E394B8876Q37268365-57D12F97-75C4-43D7-B07D-E9AEA99B10BBQ37342232-E477B200-8717-4C35-9401-A5AA4EEE48E8Q37412182-E34F02B3-A264-4970-9945-D4A15D577162Q37589114-AC02409E-878B-48FC-9466-CF246F8DA9A6Q37701328-C9D0E555-7A6A-4AD8-9792-F2E932D27A96Q37766127-8E57CE0F-46D4-480B-9598-44DBA6B8616EQ37775558-9AD8EBA0-74A0-4D13-B094-8867E0762E5BQ37826870-9DE0BF2E-4CC9-40E3-BDB6-D2B4F8411F1D
P2860
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nox2-containing NADPH oxidase ...... ced cardiomyocyte hypertrophy.
@en
type
label
Nox2-containing NADPH oxidase ...... ced cardiomyocyte hypertrophy.
@en
prefLabel
Nox2-containing NADPH oxidase ...... ced cardiomyocyte hypertrophy.
@en
P2093
P1476
Nox2-containing NADPH oxidase ...... uced cardiomyocyte hypertrophy
@en
P2093
Andrew S Peek
Jusan Yang
Ram V Sharma
Robin L Davisson
Shannon M Dunlay
Shawn D Hingtgen
P304
P356
10.1152/PHYSIOLGENOMICS.00029.2005
P577
2006-05-02T00:00:00Z